Steven Frank's most recent trade in Precigen Inc was a trade of 71,839 Common Stock done . Disclosure was reported to the exchange on March 13, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Precigen Inc | Steven Frank | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Mar 2026 | 71,839 | 1,226,391 (0%) | 0% | - | Common Stock | |
| Precigen Inc | Steven Frank | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Mar 2026 | 71,839 | 0 | - | - | Restricted Stock Units | |
| Precigen Inc | Steven Frank | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Mar 2026 | 41,073 | 41,073 | - | - | Option to Purchase Common Stock (Right to Buy) | |
| Precigen Inc | Steven Frank | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Mar 2026 | 35,612 | 35,612 | - | - | Restricted Stock Units | |
| Precigen Inc | Steven Frank | Director | Grant, award, or other acquisition of securities at price $ 3.51 per share. | 10 Mar 2026 | 14,245 | 1,154,552 (0%) | 0% | 3.5 | 50,000 | Common Stock |
| Biocryst Pharma Inc | Steven Frank | Director | Grant, award, or other acquisition of securities at price $ 8.75 per share. | 27 Feb 2026 | 1,285 | 18,903 (0%) | 0% | 8.8 | 11,244 | Common Stock |
| Biocryst Pharma Inc | Steven Frank | Director | Grant, award, or other acquisition of securities at price $ 7.18 per share. | 28 Nov 2025 | 1,566 | 17,618 (0%) | 0% | 7.2 | 11,244 | Common Stock |
| Biocryst Pharma Inc | Steven Frank | Director | Grant, award, or other acquisition of securities at price $ 8.31 per share. | 29 Aug 2025 | 1,353 | 16,052 (0%) | 0% | 8.3 | 11,243 | Common Stock |
| Biocryst Pharma Inc | Steven Frank | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jun 2025 | 27,181 | 27,181 | - | - | Automatic Stock Option Grant | |
| Biocryst Pharma Inc | Steven Frank | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jun 2025 | 12,500 | 14,699 (0%) | 0% | 0 | Common Stock | |
| Biocryst Pharma Inc | Steven Frank | Director | Grant, award, or other acquisition of securities at price $ 10.75 per share. | 30 May 2025 | 333 | 2,199 (0%) | 0% | 10.8 | 3,580 | Common Stock |
| Biocryst Pharma Inc | Steven Frank | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 May 2025 | 4,079 | 4,079 | - | - | Automatic Stock Option Grant | |
| Biocryst Pharma Inc | Steven Frank | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 May 2025 | 1,866 | 1,866 (0%) | 0% | 0 | Common Stock | |
| Precigen Inc | Steven Frank | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Mar 2025 | 87,412 | 0 | - | - | Restricted Stock Units | |
| Precigen Inc | Steven Frank | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Mar 2025 | 87,412 | 1,140,307 (0%) | 0% | - | Common Stock | |
| Precigen Inc | Steven Frank | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Mar 2025 | 83,517 | 83,517 | - | - | Option to Purchase Common Stock (Right to Buy) | |
| Precigen Inc | Steven Frank | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Mar 2025 | 71,839 | 71,839 | - | - | Restricted Stock Units | |
| Precigen Inc | Steven Frank | Director | Grant, award, or other acquisition of securities at price $ 1.74 per share. | 13 Mar 2025 | 28,735 | 1,052,895 (0%) | 0% | 1.7 | 49,999 | Common Stock |
| Precigen Inc | Steven Frank | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Mar 2024 | 101,626 | 101,626 | - | - | Option to Purchase Common Stock (Right to Buy) | |
| Precigen Inc | Steven Frank | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Mar 2024 | 87,412 | 87,412 | - | - | Restricted Stock Units | |
| Precigen Inc | Steven Frank | Director | Grant, award, or other acquisition of securities at price $ 1.43 per share. | 14 Mar 2024 | 34,965 | 1,024,160 (0%) | 0% | 1.4 | 50,000 | Common Stock |
| Precigen Inc | Steven Frank | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Mar 2024 | 106,837 | 0 | - | - | Restricted Stock Units | |
| Precigen Inc | Steven Frank | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Mar 2024 | 106,837 | 989,195 (0%) | 0% | - | Common Stock | |
| Precigen Inc | Steven Frank | Director | Purchase of securities on an exchange or from another person at price $ 1.72 per share. | 14 Aug 2023 | 400,000 | 882,358 (0%) | 0% | 1.7 | 688,000 | Common Stock |
| Precigen Inc | Steven Frank | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Mar 2023 | 125,489 | 125,489 | - | - | Option to Purchase Common Stock (Right to Buy) | |
| Precigen Inc | Steven Frank | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Mar 2023 | 106,837 | 106,837 | - | - | Restricted Stock Units | |
| Precigen Inc | Steven Frank | Director | Grant, award, or other acquisition of securities at price $ 1.17 per share. | 09 Mar 2023 | 42,735 | 482,358 (0%) | 0% | 1.2 | 50,000 | Common Stock |
| Precigen Inc | Steven Frank | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 22 Feb 2023 | 61,576 | 0 | - | - | Restricted Stock Units | |
| Precigen Inc | Steven Frank | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 22 Feb 2023 | 61,576 | 439,623 (0%) | 0% | - | Common Stock | |
| Precigen Inc | Steven Frank | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Mar 2022 | 16,212 | 378,047 (0%) | 0% | - | Common Stock | |
| Precigen Inc | Steven Frank | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Mar 2022 | 16,212 | 0 | - | - | Restricted Stock Units | |
| Precigen Inc | Steven Frank | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Feb 2022 | 83,189 | 83,189 | - | - | Option to Purchase Common Stock (Right to Buy) | |
| Precigen Inc | Steven Frank | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Feb 2022 | 61,576 | 61,576 | - | - | Restricted Stock Units | |
| Precigen Inc | Steven Frank | Director | Grant, award, or other acquisition of securities at price $ 2.03 per share. | 22 Feb 2022 | 24,630 | 361,835 (0%) | 0% | 2.0 | 49,999 | Common Stock |